Literature DB >> 12000101

Evaluation of a program to train nurses to screen for breast and cervical cancer among Native American women.

Thomas A Sellers1, Mary Alice Trapp, Robert A Vierkant, Wesley Petersen, Thomas E Kottke, Ann Jensen, Judith S Kaur.   

Abstract

BACKGROUND: Routine screening for breast and cervical cancers lowers mortality from these diseases, but the benefit has not permeated to Native American women, for whom the five-year survival rate is the lowest of any population group in the United States. To help address this problem, an educational/training program was designed to enhance the skills of nurses and other health service providers and develop clinic support systems to better recruit, screen, and follow clients for breast and cervical cancer screening services.
METHODS: A total of 131 nurses participated in the training program at 33 different sites between 1995 and 2000. Prior to and following training, each participant was given a questionnaire to determine knowledge of breast and cervical cancer screening techniques and recommendations, cancer survival and risk factors, and situational scenarios.
RESULTS: The average score for the pretest was 54% correct. The posttest average was 89% correct. The percent correct increased 35% from pre- to posttest (p < 0.001).
CONCLUSION: The knowledge to implement a successful screening program can be acquired through the current curriculum.

Entities:  

Mesh:

Year:  2002        PMID: 12000101     DOI: 10.1080/08858190209528787

Source DB:  PubMed          Journal:  J Cancer Educ        ISSN: 0885-8195            Impact factor:   2.037


  2 in total

1.  Evaluation of the breast cancer train the trainer program for nurses in Turkey.

Authors:  Ozgul Karayurt; Ayla Akkaş Gürsoy; Sultan Taşçi; Fatma Gündoğdu
Journal:  J Cancer Educ       Date:  2010-02-10       Impact factor: 2.037

2.  Impact of a community-based breast cancer screening program on Hopi women.

Authors:  S R Brown; T Nuno; L Joshweseoma; R C Begay; C Goodluck; R B Harris
Journal:  Prev Med       Date:  2011-03-01       Impact factor: 4.018

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.